These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 12424503)
1. Chrono: a community-based hypertension trial of a chronotherapeutic formulation of verapamil. Prisant LM; Black HR; Messerli F; Weber M Am J Ther; 2002; 9(6):476-83. PubMed ID: 12424503 [TBL] [Abstract][Full Text] [Related]
2. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH; Burgess ED; Assouline L; Vanjaka A Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [TBL] [Abstract][Full Text] [Related]
3. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. Smith DH; Neutel JM; Weber MA Am J Hypertens; 2001 Jan; 14(1):14-9. PubMed ID: 11206672 [TBL] [Abstract][Full Text] [Related]
4. Treatment of elderly hypertensive patients with a delayed-release verapamil formulation in a community-based trial. Weber MA; Prisant LM; Black HR; Messerli FH Am J Geriatr Cardiol; 2004; 13(3):131-6. PubMed ID: 15133416 [TBL] [Abstract][Full Text] [Related]
5. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising. White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162 [TBL] [Abstract][Full Text] [Related]
6. Chronotherapeutic oral drug absorption system verapamil is effective in reducing morning blood pressure in African Americans: a post hoc analysis of the chrono trial. Prisant LM; Weber M; Black HR J Natl Med Assoc; 2005 Mar; 97(3):377-83. PubMed ID: 15779502 [TBL] [Abstract][Full Text] [Related]
7. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131 [TBL] [Abstract][Full Text] [Related]
8. Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient. German VeraTran Hypertension Study Group. Holzgreve H; Compagnone D; Zilles P J Hum Hypertens; 1999 Jan; 13(1):61-7. PubMed ID: 9928754 [TBL] [Abstract][Full Text] [Related]
9. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [TBL] [Abstract][Full Text] [Related]
10. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study. Shimada K; Ogihara T; Saruta T; Kuramoto K; Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495 [TBL] [Abstract][Full Text] [Related]
11. Pharmacology of cardiovascular chronotherapeutic agents. Smith DH Am J Hypertens; 2001 Sep; 14(9 Pt 2):296S-301S. PubMed ID: 11583143 [TBL] [Abstract][Full Text] [Related]
12. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension. Muijsers RB; Curran MP; Perry CM Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112 [TBL] [Abstract][Full Text] [Related]
13. The treatment of severe hypertension with trandolapril, verapamil, and hydrochlorothiazide. Trandolapril/Verapamil Multicenter Study Group. Punzi HA; Novrit BA J Hum Hypertens; 1997 Aug; 11(8):477-81. PubMed ID: 9322827 [TBL] [Abstract][Full Text] [Related]
14. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy. White WB; Johnson MF; Black HR; Elliott WJ; Sica DA Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133 [TBL] [Abstract][Full Text] [Related]
15. Serum concentration and antihypertensive effect of slow-release verapamil. Schütz E; Ha HR; Bühler FR; Follath F J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S346-9. PubMed ID: 6184566 [TBL] [Abstract][Full Text] [Related]
16. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
17. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
18. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
19. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group. Messerli F; Frishman WH; Elliott WJ Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873 [TBL] [Abstract][Full Text] [Related]
20. Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil. Davis PJ; Fagan TC; Topmiller MJ; Levine JH; Ferdinand KC J Clin Pharmacol; 1995 Jan; 35(1):52-8. PubMed ID: 7751413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]